ArticleCancer cell2013

NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.

Wen Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.